Heparin sodium and Tenormin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Heparin sodium and Tenormin. Common interactions include diabetes mellitus inadequate control among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Heparin sodium and Tenormin have. It is created by eHealthMe based on reports of 52 people who take Heparin sodium and Tenormin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 16, 2023

52 people who take Heparin sodium and Tenormin together, and have interactions are studied.


What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 18,027 Heparin sodium users for its effectiveness, alternative drugs and more.

What is Tenormin?

Tenormin has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 20,076 Tenormin users for its effectiveness, alternative drugs and more.

Number of Heparin sodium and Tenormin reports submitted per year:

Heparin sodium and Tenormin drug interactions.

Common Heparin Sodium and Tenormin drug interactions by gender *:

female:

  1. Diabetes mellitus inadequate control
  2. Diarrhoea
  3. Nausea
  4. Diabetic retinopathy
  5. Fatigue
  6. Hypotension
  7. Depressed level of consciousness
  8. Pyrexia
  9. Back pain
  10. Cardiac failure

male:

  1. Dyspnoea
  2. Vomiting
  3. Nausea
  4. Spinal osteoarthritis
  5. Cardiac failure congestive
  6. Anaemia
  7. Anxiety
  8. Asthenia
  9. Bronchitis
  10. Constipation

Common Heparin Sodium and Tenormin drug interactions by age *:

0-1:

n/a

2-9:

  1. Acute respiratory failure
  2. Application site pruritus
  3. Dermatitis contact
  4. Diarrhoea
  5. Fall
  6. Gastroenteritis
  7. Gastroenteritis rotavirus
  8. Ligament sprain
  9. Pneumonia bacterial
  10. Productive cough

10-19:

n/a

20-29:

  1. Breast enlargement
  2. Breast tenderness
  3. Chest pain
  4. Dizziness
  5. Fatigue
  6. Gynaecomastia
  7. Hypoaesthesia oral
  8. Micturition urgency
  9. Syncope
  10. Vision blurred

30-39:

  1. Acute coronary syndrome
  2. Cardiac disorder
  3. Chest pain
  4. Diabetes mellitus inadequate control
  5. Chest discomfort
  6. Chills
  7. Dysphagia
  8. Dyspnoea
  9. Epistaxis
  10. Erythema

40-49:

  1. Progressive multifocal leukoencephalopathy
  2. Urinary tract infection
  3. Vomiting
  4. Aortic disorder
  5. Aphasia
  6. Cardio-respiratory arrest
  7. Carotid arterial embolus
  8. Carpal tunnel syndrome
  9. Central nervous system lesion
  10. Cerebrovascular accident

50-59:

  1. Atrial fibrillation
  2. Compartment syndrome
  3. Contusion
  4. Dyspnoea
  5. Gastritis
  6. Graft haemorrhage
  7. Haemorrhoidal haemorrhage
  8. Heparin-induced thrombocytopenia
  9. Peripheral ischaemia
  10. Tachypnoea

60+:

  1. Pleural effusion
  2. Abdominal pain
  3. Oedema
  4. Oxygen saturation decreased
  5. Pain
  6. Pollakiuria
  7. Sinusitis
  8. Cardiac failure congestive
  9. Hypotension
  10. Abdominal discomfort

Common conditions people have *:

  1. Diabetes: 6 people, 11.54%
  2. Neoplasm Malignant (cancer tumour): 5 people, 9.62%
  3. Chest Pain: 5 people, 9.62%
  4. Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 4 people, 7.69%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 7.69%
  6. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 3 people, 5.77%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium and Tenormin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Heparin sodium and Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Heparin sodium side effects:

Browse all side effects of Heparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tenormin side effects:

Browse all side effects of Tenormin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Heparin sodium interactions:

Browse all interactions between Heparin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Tenormin interactions:

Browse all interactions between Tenormin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium and atenolol (the active ingredients of Heparin sodium and Tenormin, respectively), and Heparin sodium and Tenormin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Heparin sodium and Tenormin.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: